Insider Cluster (2 insiders) ·Filed Mar 6, 2026

UTHR

UNITED THERAPEUTICS Corp
BEARISH
Impact 6/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $607K total
Actionable Insight ▼ Bearish

Monitor for potential follow-on selling or commentary on executive intent; consider whether this is routine portfolio management or a signal of reduced confidence, especially given the CEO's dominant role in the cluster.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
UTHR ▲ +14.53% at T+60d
SHORT call ✗ call lost -14.53% · α vs SPY -1.75% · entry $475.52 → $544.62
Entry anchored
Mar 5, 03:59 PM ET
via exchange tick
T+1d
+10.70%
call -10.70% · α -9.85%
$526.40
settled 7mo ago
T+5d
+12.71%
call -12.71% · α -14.24%
$535.95
settled 7mo ago
T+20d
+16.94%
call -16.94% · α -18.98%
$556.07
settled 6mo ago
T+60d
+14.53%
call -14.53% · α -1.75%
$544.62
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Chairperson & CEO Martine Rothblatt conducted a series of derivative exercises and open-market sales over a 5-day period, realizing over $2.5 million in proceeds from selling 1,500 shares, while Director Judy Olian sold $107,088 worth of stock. The majority of transactions were non-cash derivative exercises, but the open-market sales by top executives signal material insider selling.

Key Financial Metrics

Direction
selling
Total Value
$1.2M
Insiders
2

Key Facts

  • CEO Martine Rothblatt sold 1,500 shares in open-market transactions between March 12–16, 2026, for total proceeds of $1,122,078.15
  • Rothblatt also exercised derivatives for 38,000 shares (28,500 at $146.03 and 9,500 at $0), representing non-cash transactions
  • Director Judy Olian sold 200 shares for $107,088 in open-market trade
  • Total open-market selling by insiders in the cluster: $1,229,166.15
  • All transactions occurred within a 5-day window, indicating concentrated activity

Financial Impact

$1.23 million in open-market sales by insiders, with CEO responsible for ~91% of the volume

insider ownershipinvestor sentimentshareholder dilution (potential)

Risk Factors

  • Perception of insider pessimism due to concentrated selling by CEO
  • Potential for negative market reaction despite non-cash nature of most derivative exercises

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (8 trades, 7d window)cluster-UTHR-1773693124860
91 reports for UTHR
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$552.73 (+10.47%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$552.73 (+11.19%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$552.73 (+9.70%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$552.73 (+9.06%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$552.73 (+13.36%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$552.73 (+13.23%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$552.73 (+7.23%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$552.73 (+4.70%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$552.73 (+6.98%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$552.73 (+6.98%)
Showing 10 of 91

US Market Status

Market Open — Closes in 4h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 16, 2026